Vision
Our vision is to redefine the global standard for injectable drug delivery, making it smaller, safer, and more efficient, so critical medications can reach more people with less waste, lower cost, and greater reliability.
The Smallest Practical Form Factor for a Prefilled Syringe
xJect-MICRON achieves a breakthrough in syringe miniaturization through a fundamentally reengineered architecture that eliminates unnecessary volume while preserving full functionality. By reducing overall size by up to 40%, it lowers storage, packaging, and transport demands without compromising safety, reliability, or dose accuracy. The result is a highly efficient prefilled syringe platform designed to meet the needs of modern pharmaceutical manufacturing and global healthcare delivery.
About xJect
xJect was founded to rethink one of healthcare’s most essential devices: the prefilled syringe. While injectable therapies have advanced dramatically, syringe design has remained largely unchanged for decades.
We believe efficiency, safety, and scalability begin at the design level. By reengineering the architecture of the prefilled syringe, xJect reduces size, minimizes waste, and improves reliability across storage, transport, and administration.
Our patented platform is built to support modern pharmaceutical manufacturing and global distribution, enabling a more efficient and resilient healthcare supply chain.
Ultra-compact
Design
Up to 40% smaller than conventional prefilled syringes, reducing storage footprint and overall supply chain burden.
Designed for measurable operational impact:
-
Automatic mechanism with no snap-off or snap-on components. No assembly required
-
No additional parts compared to a standard prefilled syringe architecture
Simplified
Logistics
The ultra-compact design of xJect-MICRON enables more efficient packaging, transport, and handling, improving distribution efficiency across healthcare systems worldwide.
Operational and global distribution advantages include:
-
Lower shipping costs through increased packaging density
-
Reduced storage space requirements across warehouses and healthcare facilities
-
Lower cold-chain transport and storage burden, reducing energy and infrastructure demands
-
Improved deployment efficiency in emergencies, including pandemics, humanitarian crises, and remote or resource-limited environments
Enhanced
Safety
xJect-MICRON incorporates multiple safety features designed to protect patients, healthcare providers, and the supply chain:
-
Leak-resistant design ensures accurate and complete dose delivery
-
Auto-disabling feature prevents reuse and enhances patient safety
-
Shatter-resistant, reinforced architecture improves durability during handling and transport
Expanded
Global Access
Improved efficiency and reduced logistics burden enable medications to reach more patients, including in resource-limited and remote regions.
Global impact advantages include:
-
Increased shipment capacity per transport unit, enabling broader geographic coverage
-
Reduced cold-chain dependency, supporting deployment in infrastructure-limited regions
-
More efficient stockpiling for vaccination campaigns and public health initiatives
-
Faster distribution during pandemics, humanitarian emergencies, and crisis response operations
-
Lower overall delivery cost per dose, improving affordability at scale
Our Product:
xJect-MICRON
xJect MICRON is an ultra-compact, prefilled syringe engineered to reduce size, minimize waste, and ensure reliable, precise dose delivery. Its patented design improves safety, simplifies handling and logistics, and enables scalable distribution across global healthcare systems. By rethinking syringe architecture from the ground up, xJect MICRON makes injectable therapies more efficient, safer, and accessible to patients worldwide.
US & International Patents Pending
xJect MICRON’s patented design protects its ultra-compact, safe, and efficient syringe architecture, ensuring a unique and defensible innovation in injectable drug delivery.
Benefits
01
Transport Efficiency
02
Shipping Costs
03
Storage Costs
04
Cold-chain Costs
05
Rapid Response
06
Durability/Shatter Resistance
07
Guaranteed Dose Delivery
08
Syringe Reuse Prevention
09
Packaging
10
Carbon Emissions
11
Waste
12
Cost per Dose
US & International Patents Pending
xJect technology is protected by patent applications in the United States and key international jurisdictions. These filings cover the core architecture, integrated mechanism, and compact design that enable a significantly smaller, leak-safe prefilled syringe. This intellectual property establishes a strong foundation for long-term differentiation and commercialization.
Strategic Partners
xJect collaborates with leading healthcare, research, and innovation organizations to accelerate development and bring next-generation prefilled syringe technology to market. These strategic partners provide expertise in medical device development, clinical insight, engineering, and commercialization, helping ensure xJect meets the highest standards of safety, reliability, and real-world performance. Together, we are advancing more efficient, scalable, and resilient drug delivery solutions for global healthcare.
_sml.png)
Resources
In 2015, the World Health Organization recommended the global adoption of smart syringes to prevent reuse, improve safety, and reduce the risk of infections. xJect MICRON aligns with this initiative by providing a compact, safe, and reliable prefilled syringe for modern healthcare.
A World Health Organization overview of how vaccine supply chains and logistics systems must function to keep vaccines available, safe, and delivered efficiently — highlighting systemic pressures around distribution, cold chain, and waste management.
This clinical study found that prefilled syringes remain safe, sterile, and effective when prepared in advance and stored properly. The research showed no contamination and confirmed that prefilled syringes can help save time and improve efficiency in clinical settings, making them a reliable option for healthcare providers.
This study evaluates a compact pre-filled auto-disable injection system (cPAD) for delivering the pentavalent vaccine in Cambodia, Ghana, and Peru. Results show cPAD can reduce vaccine wastage, simplify administration, and lower costs per fully immunized child, highlighting the benefits of compact, pre-filled delivery systems for safer and more efficient immunization programs.
This article (PMID 35648471) highlights the global need for safe, reliable syringes, especially for COVID‑19 and other vaccines. It explains that supply shortages, shipping delays, and mismatched syringe types have caused problems in many regions. The authors recommend stockpiling, standardizing doses, and expanding production to ensure vaccines are delivered safely and efficiently worldwide.
The WHO guidance provides countries with practical advice on how to store, transport, and distribute COVID‑19 vaccines safely. It covers managing the cold chain, tracking vaccine use, handling waste, and preparing vaccination sites to ensure vaccines reach people efficiently and remain effective.
The WHO guidance provides countries with practical advice on how to store, transport, and distribute COVID‑19 vaccines safely. It covers managing the cold chain, tracking vaccine use, handling waste, and preparing vaccination sites to ensure vaccines reach people efficiently and remain effective.
The WIRED article highlights WHO’s push for “smart syringes” that prevent reuse, aiming to reduce the spread of infections like HIV and hepatitis.
A clear overview of why medical logistics matter, covering timely delivery of critical supplies, cost control, inventory visibility, regulatory compliance, and how strong logistics support scalable, resilient healthcare systems.
Get in touch
Get the latest on xJect technology and partnership opportunities.